$ACRE
Ares Commercial Real Estate Corp Stock $acre

$acre Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023014732 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$51.94M	$26.50M
YoY Change	106.56%	10.32%
Cost Of Revenue	$30.29M	$26.01M
YoY Change	75.66%	66.03%
Gross Profit	$21.66M	$23.49M
YoY Change	1.29%	15.32%
Gross Profit Margin	41.69%	88.64%
Selling, General & Admin	$3.773M	$3.188M
YoY Change	8.33%	-53.5%
% of Gross Profit	17.42%	13.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$0.00
YoY Change
% of Gross Profit		0.0%
Operating Expenses	$23.90M	$29.82M
YoY Change	112.43%	376.21%
Operating Profit	-$2.244M	-$6.329M
YoY Change	-122.15%	-144.86%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.244M	-$6.329M
YoY Change	-122.15%	-138.81%
Income Tax	-$46.00K	$110.0K
% Of Pretax Income
Net Earnings	-$2.198M	-$6.439M
YoY Change	-121.91%	-139.74%
Net Earnings / Revenue	-4.23%	-24.3%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	-$0.12
COMMON SHARES
Basic Shares Outstanding	54.67M shares	54.61M shares
Diluted Shares Outstanding	54.35M shares	54.59M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$142.6M	$153.8M
YoY Change	456.5%	1017.55%
Cash & Equivalents	$142.6M	$153.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$142.6M	$153.8M
YoY Change	456.5%	1017.55%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$27.97M	$28.01M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.257B	$2.291B
YoY Change	-15.48%	-8.45%
TOTAL ASSETS
Total Short-Term Assets	$142.6M	$153.8M
Total Long-Term Assets	$2.257B	$2.291B
Total Assets	$2.400B	$2.444B
YoY Change	-10.99%	-2.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.99M	$23.25M
YoY Change	0.95%	13.04%
LONG-TERM LIABILITIES
Long-Term Debt	$1.670B	$1.688B
YoY Change	-10.98%	-6.03%
Other Long-Term Liabilities	$14.63M	$15.02M
YoY Change	40.19%	53.4%
Total Long-Term Liabilities	$1.685B	$1.703B
YoY Change	-10.69%	-5.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.99M	$23.25M
Total Long-Term Liabilities	$1.685B	$1.703B
Total Liabilities	$1.709B	$1.726B
YoY Change	-10.55%	-5.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$120.5M	-$99.11M
YoY Change	214.29%	239.77%
Common Stock	$810.7M	$814.3M
YoY Change	-0.15%	15.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$691.2M	$718.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.400B	$2.444B
YoY Change	-10.99%	-2.84%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.198M	-$6.439M
YoY Change	-121.91%	-139.74%
Depreciation, Depletion And Amortization		$0.00
YoY Change
Cash From Operating Activities	$11.90M	$11.26M
YoY Change	-8.02%	-30.58%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$19.24M	$70.06M
YoY Change	-111.6%	-21.88%
Cash From Investing Activities	$19.24M	$70.06M
YoY Change	-111.6%	-21.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-42.30M	-$68.83M
YoY Change	-125.67%	-51.78%
NET CHANGE
Cash From Operating Activities	11.90M	$11.26M
Cash From Investing Activities	19.24M	$70.06M
Cash From Financing Activities	-42.30M	-$68.83M
Net Change In Cash	-11.16M	$12.49M
YoY Change	-194.06%	-133.88%
FREE CASH FLOW
Cash From Operating Activities	$11.90M	$11.26M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001529377
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35517
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ARES COMMERCIAL REAL ESTATE CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-3148087
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	245 Park Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	42nd Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10167
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	750-7300
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	ACRE
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54672238	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153764000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	141278000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	2173205000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	2264008000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	87502000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65969000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	2085703000	usd
CY2022Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	2198039000	usd
CY2023Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	27375000	usd
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	28007000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	27936000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	149471000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	155749000	usd
CY2023Q1	us-gaap	Assets Assets	2444320000	usd
CY2022Q4	us-gaap	Assets Assets	2523002000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	698153000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	705231000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	104509000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	104460000	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	149247000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	149200000	usd
CY2023Q1	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	735839000	usd
CY2022Q4	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	777675000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3899000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5580000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	19346000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	19347000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	15024000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	13969000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1726017000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1775462000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54606826	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54606826	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54443983	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54443983	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	537000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	537000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	813748000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	812788000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3129000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7541000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99111000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73326000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	718303000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	747540000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2444320000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2523002000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	49500000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	33364000	usd
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	22999000	usd
CY2022Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	12013000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	26501000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21351000	usd
CY2023Q1	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	0	usd
CY2022Q1	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	2672000	usd
CY2023Q1	us-gaap	Revenues Revenues	26501000	usd
CY2022Q1	us-gaap	Revenues Revenues	24023000	usd
CY2023Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	3010000	usd
CY2022Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2974000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	771000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	778000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1685000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1613000	usd
CY2023Q1	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	732000	usd
CY2022Q1	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	834000	usd
CY2023Q1	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	0	usd
CY2022Q1	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	4309000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	6198000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	10508000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	21019000	usd
CY2022Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	-594000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	-5613000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47654549	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2022Q1	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2197000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6329000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16306000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	110000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6439000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	16201000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54591650	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47204397	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54591650	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6439000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	16201000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-4477000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	7614000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	65000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10851000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23815000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	678628000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2874000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	9000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	766000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7614000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	16201000	usd
CY2022Q1	us-gaap	Dividends Cash DividendsCash	16740000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	689334000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	103393000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	190000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	699000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1931000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	10031000	usd
CY2022Q2	us-gaap	Dividends Cash DividendsCash	19198000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	786000000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	34000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	673000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1010000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	644000	usd
CY2022Q3	us-gaap	Dividends Cash DividendsCash	19196000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	767077000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	738000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3838000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2909000	usd
CY2022Q4	us-gaap	Dividends Cash DividendsCash	19346000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	747540000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	960000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4412000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6439000	usd
CY2023Q1	us-gaap	Dividends Cash DividendsCash	19346000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	718303000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6439000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	16201000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	979000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2220000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	1779000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	2280000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	960000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	766000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	21019000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-594000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	-5613000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	0	usd
CY2023Q1	us-gaap	Amortization Of Deferred Hedge Gains AmortizationOfDeferredHedgeGains	-456000	usd
CY2022Q1	us-gaap	Amortization Of Deferred Hedge Gains AmortizationOfDeferredHedgeGains	0	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2197000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8617000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3956000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-1681000	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-333000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1657000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1524000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11256000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16215000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	18378000	usd
CY2022Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	217549000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	78198000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	266574000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	9825000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	0	usd
CY2023Q1	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	413000	usd
CY2022Q1	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	2428000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	38227000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	70058000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	89680000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	28275000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	297000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	651000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	42106000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	19347000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	16674000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	2874000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-68828000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-142751000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12486000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36856000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141278000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50615000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153764000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13759000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Global macroeconomic conditions, including high inflation, changes to fiscal and monetary policy, high interest rates, potential market-wide liquidity problems, currency fluctuations, labor shortages and challenges in the supply chain, have the potential to negatively impact the Company and its borrowers. These current macroeconomic conditions may continue or aggravate and could cause the United States economy or other global economies to experience an economic slowdown or recession. We anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States or other major global economy. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2023, however, uncertainty over the global economy and the Company’s business, makes any estimates and assumptions as of March 31, 2023 inherently less certain than they would be absent the current and potential impacts of current macroeconomic conditions. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	22999000	usd
CY2022Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	12013000	usd
CY2023Q1	srt	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	53	loan
CY2023Q1	acre	Mortgage Loans On Real Estate Number Of Loans Repaid Or Sold Since Inception MortgageLoansOnRealEstateNumberOfLoansRepaidOrSoldSinceInception	157	loan
CY2023Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount MortgageLoansOnRealEstateTotalCommitmentAmount	2500000000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Excluding Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountExcludingNoncontrollingInterest	2200000000	usd
CY2023Q1	acre	Payments To Acquire Loans Held For Investment Including Non Cash Upsize And Excluding Capitalized Funding PaymentsToAcquireLoansHeldForInvestmentIncludingNonCashUpsizeAndExcludingCapitalizedFunding	26400000	usd
CY2023Q1	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	72800000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Number Of Loans Sold MortgageLoansOnRealEstateNumberOfLoansSold	1	loan
CY2023Q1	us-gaap	Principal Amount Outstanding On Loans Held For Sale Or Securitization PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization	14300000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Number Of Loans Transferred MortgageLoansOnRealEstateNumberOfLoansTransferred	1	loan
CY2023Q1	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	27400000	usd
CY2023Q1	acre	Percentage Of Loans Held For Investment Having Libor Floors PercentageOfLoansHeldForInvestmentHavingLIBORFloors	0.808
CY2023Q1	acre	Loans Receivable Description Of Variable Rate Basis Weighted Average Floor LoansReceivableDescriptionOfVariableRateBasisWeightedAverageFloor	0.0099
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	2173205000	usd
CY2023Q1	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	2194914000	usd
CY2023Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Including Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldIncludingNonaccrualLoans	0.085
CY2023Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Excluding Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldExcludingNonaccrualLoans	0.092
CY2023Q1	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y4M24D
CY2022Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	2264008000	usd
CY2022Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	2282821000	usd
CY2022Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Including Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldIncludingNonaccrualLoans	0.085
CY2022Q1	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Excluding Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldExcludingNonaccrualLoans	0.089
CY2022Q1	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y4M24D
CY2023Q1	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	2194900000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	2173200000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Unleveraged Effective Yield MortgageLoansOnRealEstateUnleveragedEffectiveYield	0.085
CY2023Q1	acre	Loans Receivable Borrower Extension Period LoansReceivableBorrowerExtensionPeriod	P1Y
CY2022Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	2264008000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	0	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Receipt Of Origination Fee MortgageLoansOnRealEstateReceiptOfOriginationFee	413000	usd
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	26363000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Amortizing Payments MortgageLoansOnRealEstateAmortizingPayments	4671000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Loan Paid Off MortgageLoansOnRealEstateLoanPaidOff	72366000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Loan Sold MortgageLoansOnRealEstateLoanSold	14324000	usd
CY2023Q1	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	27165000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1773000	usd
CY2023Q1	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	2173205000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	-5600000	usd
CY2023Q1	acre	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest Number Of Loans FinancingReceivableAllowanceForCreditLossExcludingAccruedInterestNumberOfLoans	2	loan
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	92300000	usd
CY2023Q1	acre	Mortgage Loanson Real Estate Commitment Reserveor Allowancefor Credit Loss Basis Points MortgageLoansonRealEstateCommitmentReserveorAllowanceforCreditLossBasisPoints	387
CY2023Q1	acre	Commitments Commitments	2400000000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	953153000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1535000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	960231000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1535000000	usd
CY2019Q4	acre	Number Of Non Recourse Notes NumberOfNonRecourseNotes	2	loan
CY2023Q1	us-gaap	Derivative Exchange Rate Floor1 DerivativeExchangeRateFloor1	0.0000
CY2023Q1	acre	Commitments Commitments	2388338000	usd
CY2022Q4	acre	Commitments Commitments	2510308000	usd
CY2023Q1	acre	Funded Commitments FundedCommitments	2194914000	usd
CY2022Q4	acre	Funded Commitments FundedCommitments	2282821000	usd
CY2023Q1	acre	Unfunded Commitments UnfundedCommitments	193424000	usd
CY2022Q4	acre	Unfunded Commitments UnfundedCommitments	227487000	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	848609	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	169452	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	3333	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	675824	shares
CY2023Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestinthe Remainderofthe Year ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestintheRemainderoftheYear	12874	shares
CY2023Q1	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Two ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearTwo	285406	shares
CY2023Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Three ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearThree	232848	shares
CY2023Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Four ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFour	144696	shares
CY2023Q1	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Five ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFive	0	shares
CY2023Q1	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants To Date ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsToDate	675824	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6439000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6439000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16201000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16201000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54591650	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47204397	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	450152	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54591650	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47654549	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	682620	shares
CY2023Q1	acre	Excise Taxes Rate ExciseTaxesRate	0.04
CY2023Q1	acre	Loan Mortgage Held For Sale Fair Value Disclosure Number Of Loans LoanMortgageHeldForSaleFairValueDisclosureNumberOfLoans	1	loan
CY2022	acre	Number Of Debt Securities Available For Sale Purchased With Credit Deterioration Amount At Purchase Price NumberOfDebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice	3	loan
CY2022	us-gaap	Debt Securities Available For Sale Purchased With Credit Deterioration Amount At Purchase Price DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice	27900000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Term DebtSecuritiesAvailableForSaleTerm	P10Y
CY2022Q4	acre	Number Of Debt Securities Available For Sale NumberOfDebtSecuritiesAvailableForSale	3	investment
CY2023Q1	acre	Number Of Debt Securities Available For Sale NumberOfDebtSecuritiesAvailableForSale	3	investment
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	28000000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	27887000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Purchased With Credit Deterioration Discount Premium DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationDiscountPremium	113000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	120000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	28000000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	27881000	usd
CY2022	us-gaap	Debt Securities Available For Sale Purchased With Credit Deterioration Discount Premium DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationDiscountPremium	119000	usd
CY2022	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	55000	usd
CY2023Q1	us-gaap	Dividends Dividends	19346000	usd
CY2022Q1	acre	Related Party Transaction Amendment To Management Agreement Real Estate Revenues Excluded From Net Income RelatedPartyTransactionAmendmentToManagementAgreementRealEstateRevenuesExcludedFromNetIncome	2400000	usd
CY2022Q1	acre	Related Party Transaction Amendment To Management Agreement Gain On Interest Rate Cap Derivatives Revenues Included In Net Income RelatedPartyTransactionAmendmentToManagementAgreementGainOnInterestRateCapDerivativesRevenuesIncludedInNetIncome	2000000	usd
CY2023Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	0	usd
CY2022Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	358000	usd
CY2023Q1	acre	Related Party Transactions Management Fee Renewal Term RelatedPartyTransactionsManagementFeeRenewalTerm	P1Y
CY2023Q1	acre	Related Party Transactions Termination Fee Based On Average Annual Management And Incentive Fees Ratio RelatedPartyTransactionsTerminationFeeBasedOnAverageAnnualManagementAndIncentiveFeesRatio	3
CY2023Q1	acre	Related Party Transactions Management Fee Look Back Period RelatedPartyTransactionsManagementFeeLookBackPeriod	P24M
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Dividends Dividends	19346000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2022Q1	us-gaap	Dividends Dividends	16740000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2022Q1	us-gaap	Dividends Dividends	16740000	usd
CY2023Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.33
CY2023Q1	acre	Common Stock Dividends Per Share Supplemental Cash Dividend CommonStockDividendsPerShareSupplementalCashDividend	0.02
CY2023Q1	acre	Receivables Related To Repayments Of Outstanding Principal On Previous Mortgage Assets ReceivablesRelatedToRepaymentsOfOutstandingPrincipalOnPreviousMortgageAssets	128300000	usd
CY2022Q4	acre	Receivables Related To Repayments Of Outstanding Principal On Previous Mortgage Assets ReceivablesRelatedToRepaymentsOfOutstandingPrincipalOnPreviousMortgageAssets	127600000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	238200000	usd

Files In Submission

Name	View Source	Status
0001628280-23-014732-index-headers.html	Edgar Link	pending
0001628280-23-014732-index.html	Edgar Link	pending
0001628280-23-014732.txt	Edgar Link	pending
0001628280-23-014732-xbrl.zip	Edgar Link	pending
acre-20230331.htm	Edgar Link	pending
acre-20230331.xsd	Edgar Link	pending
acre-20230331_g1.jpg	Edgar Link	pending
acreq1-23exhibit311.htm	Edgar Link	pending
acreq1-23exhibit312.htm	Edgar Link	pending
acreq1-23exhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
acre-20230331_def.xml	Edgar Link	unprocessable
acre-20230331_lab.xml	Edgar Link	unprocessable
acre-20230331_pre.xml	Edgar Link	unprocessable
acre-20230331_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
acre-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACRE
Ares Commercial Real Estate Corp Stock $acre

2023 Q2 Form 10-Q Financial Statement

#000162828023014732 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE Ares Commercial Real Estate Corp Stock $acre

2023 Q2 Form 10-Q Financial Statement

#000162828023014732 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE
Ares Commercial Real Estate Corp Stock $acre